Safe administration of ipilimumab plus nivolumab to a dialysis patient with renal cell carcinoma.
Takuya IwakiAya NiimiMasato KanoYoshiaki KurokawaUran YoshizakiKeina NozakiAkira NomiyaHideyo MiyazakiHaruki KumePublished in: IJU case reports (2020)
The combination of ipilimumab plus nivolumab was safely used in a hemodialysis patient with metastatic renal cell carcinoma.